Neurosteer’s Peer-Reviewed Publication: Evaluation of Parkinson’s Disease Early Diagnosis with Neurosteer’s hdrEEG™ System

Dec 19, 2023

Neurosteer’s Peer-Reviewed Publication: Evaluation of Parkinson’s Disease Early Diagnosis with Neurosteer’s hdrEEG™ System


NEW YORK, Dec. 19, 2023 -- Neurosteer Inc. announces the publication of our groundbreaking paper in Frontiers in Neurology detailing a revolutionary approach to Parkinson's disease detection and differentiation using our pocket-sized hdrEEG™ system and a rapid 15-minute auditory assessment.disorders.


The study was performed using Neurosteer’s FDA cleared medical-grade hdrEEG™ system which represents a breakthrough in brain “scanning” and offers a completely novel approach to analyzing brain activity.


The system is designed to support early detection and differentiation of neurodegenerative disorders and continuous brain monitoring in the ICU.disorders.


Neurosteer’s wireless, pocket-sized, medical-grade wearable device, with its innovative forehead-attached electrode adhesive strip, can be used anywhere. It is low cost, massively deployable, automatic and objective.


In conjunction with the device, our noninvasive, 15-minute auditory brain health assessment was used in the study for the detection of Parkinson's disease.


Paired with our cloud-based signal processing server, our system showed excellent correlation to F-DOPA PET scans in detecting and differentiating Parkinson’s disease, for a fraction of the cost, in a simple to operate, noninvasive, 15 minute procedure that can be performed virtually anywhere.


By contrast, today’s Parkinson’s disease assessments using F-DOPA PET scanners are invasive, cumbersome, and extremely expensive, and require a dedicated facility and subjective interpretation by clinicians. As a result, they are only performed after the onset of symptoms, by which time it may be too late for effective treatment.


Preliminary data suggests similar promise for Alzheimer’s disease, making it ideal for patient screening to benefit from recent Alzheimer’s drugs.


The company intends to establish a new standard of care in brain assessment and revolutionize early detection of Parkinson’s, Alzheimer’s and other neurodegenerative disorders.


MORE INFO

Neurosteer to Present at ApplySci MIT

01 Sep, 2023
Neurosteer founder and CEO, Nathan Intrator PhD, has been invited to be a main speaker at the ApplySci AI + Deep Tech + NeuroTech conference at MIT later this month.

Brain Activity and Music as Seen with Neurosteer’s hdrEEG™ System

20 Jun, 2023
In “This Is What Music Does to Your Brain,” Yael Hallak of Haaretz writes that new research is exploring how to use music to bring people closer and even to diagnose cognitive decline in the elderly.

Neurosteer Announces FDA Clearance of the Neurosteer EEG Brain Monitoring Platform

03 Nov, 2022
Neurosteer Inc. announces FDA clearance of its Neurosteer® single-channel EEG brain monitoring platform. The clearance allows Neurosteer’s unobtrusive multi-purpose system to be used in a broad range of clinical settings, including the ICU, a doctor’s office, and pharma drug trials.

Neurosteer Delivers Real-Time Brain Monitoring to Peter Gabriel Reverberation Event

By Neurosteer • 23 Oct, 2022
Neurosteer participated in Peter Gabriel’s event at the Fotografiska Museum in NYC, demonstrating the effect of music and meditation on the brain using real-time graphics by displaying brain activity as it related to the intensity of focus, relaxation, and emotion.

Israeli Scientists Say Brain Analysis Tool Can Spot Cognitive Decline – Using Music

By Times of Israel • 26 Aug, 2022
A Tel Aviv University PhD student, Neta Maimon, came up with a 15-minute test that supports early detection of cognitive decline. The test uses musical cues in conjunction with Neurosteer’s EEG brain monitoring system to track brain function as elderly people listen to music.

Neurosteer Wins Roche Alzheimer’s Innovation Challenge

By Roche & Startup Nation Central • 14 Jul, 2022
Neurosteer was the winner of the Roche for a Better Future: Alzheimer’s Innovation Challenge , launched by Roche and Start-Up Nation Central with the vision of early detection and enhanced digital health support for Alzheimer’s disease patients and their caregivers.

Brain Health – Company of the Year Award

By Neurosteer • 15 Dec, 2019
Neurosteer received the “Brain Health Company of the Year” award from Tradex News . It has been a great year for us, most notably in improving our product for early screening of Alzheimer’s, Parkinson’s and fronto-temporal dementia.

The Effect of Music on Our Brain

By Neurosteer • 19 Nov, 2019
Following recent fMRI studies on the effect of music on the brain, Israeli TV Channel 13 interviewed Neta Maimon , a PhD student in music cognition at Tel Aviv University and a researcher at Neurosteer. Using Neurosteer sensing technology on a group of brain-monitored study participants, emotional and cognitive responses to songs were clearly visible. 

Monitoring Two Runners During the NYC Marathon

By Neurosteer • 03 Nov, 2019
Neurosteer monitored two runners, in real time, during the NYC marathon on Nov 3rd. Prof. Steven Laureys, a key figure in the European Human Brain Project, was behind this initiative, which created significant interest in sports and other brain monitoring in extreme physical conditions. The article in DeMorgen describes it (in Dutch; use Google Translate). The full event was streamed live on Facebook . When going over the recording, one can see that Steven was meditating during much of the run (a well-known method to reduce oxygen consumption). 

Monitoring and Assessing Surgeons at the ACS Conference

By Neurosteer • 30 Oct, 2019
Neurosteer, together with Stanford Prof. Carla Pugh, is quantifying and assessing surgeon performance before and during surgery as part of the Stanford Surgical Metrics project. During the American College of Surgeons conference in San Fransisco, brain activity data from more than 200 surgeons was collected. Check out the video to see the cognitive assessment and monitoring during simulated surgery. This illustrates an application of Neurosteer’s platform for the evaluation of cognitive performance of healthy subjects. The same setup can be used to monitor pilots and others during critical missions.
More Posts
Share by: